LISA SATTER to Janus Kinase Inhibitors
This is a "connection" page, showing publications LISA SATTER has written about Janus Kinase Inhibitors.
Connection Strength
1.453
-
Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors. Am J Respir Crit Care Med. 2020 09 15; 202(6):893-897.
Score: 0.673
-
STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition. N Engl J Med. 2020 10 08; 383(15):1494-1496.
Score: 0.338
-
Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study. Lancet Rheumatol. 2025 Jun; 7(6):e391-e402.
Score: 0.229
-
JAK/STAT defects and immune dysregulation, and guiding therapeutic choices. Immunol Rev. 2024 03; 322(1):311-328.
Score: 0.213